State-of-the-art chemoradiation is no substitution for trimodality approach in the treatment of locally advanced thoracic esophageal squamous cell carcinoma

State-of-the-art chemoradiation is no substitution for trimodality approach in the treatment of locally advanced thoracic esophageal squamous cell carcinoma

Bibliographic Details
Main Authors:	Hsin-Yi Yang, Kai-Sheng Liao, Cheng-Yen Lee, Kam-Hong Kam
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423004013

Similar Items

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
by: Xiaokun Li, et al.
Published: (2022-07-01)

The impact of histological variants of urothelial carcinoma on clinical outcomes following trimodality bladder-sparing chemoradiation
by: Kiltie, A, et al.
Published: (2017)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
by: Chi Zhang, et al.
Published: (2023-01-01)

Definitive chemoradiation therapy or surgery for clinical T1-3N0-1M0 thoracic esophageal squamous cell carcinoma: A propensity score matching analysis
by: Xu-Yuan Li, et al.
Published: (2019-01-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2023-04-01)

Multimodal Treatment Strategies to Improve the Prognosis of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Narrative Review
by: Tadashi Higuchi, et al.
Published: (2022-12-01)

Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
by: Hui Li, et al.
Published: (2022-06-01)

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma
by: Qingwu Du, et al.
Published: (2023-07-01)

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
by: Zhen Wang, et al.
Published: (2022-06-01)

Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
by: Francesco Cavallin, et al.
Published: (2017-05-01)

Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma
by: Qingwu Du, et al.
Published: (2023-07-01)

Is Tumor Regression Grade Sufficient to Predict Survival in Esophageal Cancer with Trimodal Therapy?
by: Yi-Min Gu, et al.
Published: (2022-10-01)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
by: Roman O. Kowalchuk, et al.
Published: (2023-02-01)

Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
by: Ruixi Wang, et al.
Published: (2022-10-01)

Synchronous advanced gastric adenocarcinoma and advanced esophageal squamous cell carcinoma
by: Fernando Augusto Mardiros Herbella, et al.
Published: (2002-01-01)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
by: Dongryul Oh, et al.
Published: (2020-08-01)

Bilateral video-assisted thoracic surgery for esophageal cancer with left inferior pulmonary vein invasion following chemoradiation therapy
by: Masakazu Fujii, et al.
Published: (2023-07-01)

High TLR6 Expression Status Predicts a More Favorable Prognosis after Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
by: Yusuke Sato, et al.
Published: (2023-05-01)

Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy
by: Takahiro Mori, et al.
Published: (2021-01-01)

Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes
by: Gen Suzuki, et al.
Published: (2022-11-01)

A retrospective analysis of concurrent chemoradiation for squamous cell carcinoma of the anus in Johannesburg
by: Phemelo Tshoeu, et al.
Published: (2023-09-01)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
by: Dirk Rades, et al.
Published: (2023-06-01)

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma
by: Yu Lin, et al.
Published: (2023-04-01)

The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma
by: Hayato Kaida, et al.
Published: (2022-11-01)

Chemoradiation of pancreatic carcinoma
by: Erdinç Nayır, et al.
Published: (2016-08-01)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
by: Ting Qian MS, et al.
Published: (2024-03-01)

Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
by: Akira Ooki, et al.
Published: (2023-01-01)

Does time to esophagectomy following neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma affect outcomes?
by: Zhi-Nuan Hong, et al.
Published: (2022-10-01)

Clinical and genomic characterization of chemoradiation-resistant HPV-positive oropharyngeal squamous cell carcinoma
by: Theresa Guo, et al.
Published: (2024-03-01)

Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
by: Shau-Hsuan Li, et al.
Published: (2021-06-01)

A Case of Esophageal Squamous Cell Carcinoma Arising from Esophageal Squamous Papilloma
by: Jae Yeong Cho, et al.
Published: (2019-01-01)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
by: Zheng Lin, et al.
Published: (2022-06-01)

Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
by: Renxian Xie, et al.
Published: (2024-01-01)

Immune checkpoint inhibitors combined with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Jiang-Qiong Huang, et al.
Published: (2024-03-01)

Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
by: Wei-Cheng Lin, et al.
Published: (2019-10-01)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
by: Hirsch Matani, et al.
Published: (2022-11-01)

Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
by: Yao‐Hung Kuo, et al.
Published: (2020-01-01)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
by: Chengzhi Ding, et al.
Published: (2023-12-01)